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IMPORTANCE Risk assessment tools for exercise treadmill testing may have limited external

validity. Cardiovascular mortality has decreased in recent decades, and women have been
underrepresented in prior cohorts.

Supplemental content at
jamacardiology.com

OBJECTIVES To determine whether exercise and clinical variables are associated with
differential mortality outcomes in men and women and to assess whether sex-specific risk
scores better estimate all-cause mortality.
DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study included 59 877
patients seen at the Cleveland Clinic Foundation (CCF cohort) from January 1, 2000, through
December 31, 2010, and 49 278 patients seen at the Henry Ford Hospital (FIT cohort) from
January 1, 1991, through December 31, 2009. All patients were 18 years or older and
underwent exercise treadmill testing. Data were analyzed from January 1, 2000, to October
27, 2011, in the CCF cohort and from January 1, 1991, to April 1, 2013, in the FIT cohort.
MAIN OUTCOMES AND MEASUREMENTS The CCF cohort was divided randomly into derivation
and validation samples, and separate risk scores were developed for men and women. Net
reclassification, C statistics, and integrated discrimination improvement were used to
compare the sex-specific risk scores with other tools that have all-cause mortality as the
outcome. Discrimination and calibration were also evaluated with these sex-specific risk
scores in the FIT cohort.
RESULTS The CCF cohort included 59 877 patients (59.4% men; 40.5% women) with a
median (interquartile range [IQR]) age of 54 (45-63) years and 2521 deaths (4.2%) during a
median follow-up of 7 (IQR, 4.1-9.6) years. The FIT cohort included 49 278 patients (52.5%
men; 47.4% women) with a median (IQR) age of 54 (46-64) years and 6643 deaths (13.5%)
during a median (IQR) follow-up of 10.2 (7-13.4) years. C statistics for the sex-specific risk
scores in the CCF validation sample were higher (0.79 in women and 0.81 in men) than
C statistics using other tools in women (0.70 for Duke Treadmill Score; 0.74 for Lauer
nomogram) and men (0.72 for Duke Treadmill Score; 0.75 for Lauer nomogram). Net
reclassification and integrated discrimination improvement were superior with the
sex-specific risk scores, mostly owing to correct reclassification of events. The sex-specific
risk scores in the FIT cohort demonstrated similar discrimination (C statistic, 0.78 for women
and 0.79 for men), and calibration was reasonable.
CONCLUSIONS AND RELEVANCE Sex-specific risk scores better estimate mortality in patients
undergoing exercise treadmill testing. In particular, these sex-specific risk scores help to
identify patients at the highest residual risk in the present era.
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E

xercise testing is recommended to assess prognosis in
patients with known or suspected coronary artery disease (CAD) who present with symptoms suggestive of
worsening ischemic heart disease.1 For nearly 3 decades, the
Duke Treadmill Score (DTS) has been the standard to assess
prognosis in these patients.2 However, during the past few decades, advances in therapy have dramatically reduced cardiovascular mortality,3 and the validity of this score in a contemporary population is unclear. The DTS was also developed in
a predominantly male population, and a paucity of data regarding risk stratification with this score exists in women.4
Finally, the DTS incorporates only exercise duration,
ST-segment depression, and exercise-induced chest pain.2
Other exercise variables are associated with prognosis,5-7 and
many of these patients have cardiovascular comorbidities that
also affect their overall risk.
To address this latter concern, a nomogram was created
by Lauer and colleagues8 that is superior to the DTS at predicting all-cause mortality. The broader clinical use of this nomogram is unclear and in part has been limited by exclusion
of certain patient populations, including those with known
CAD, valvular heart disease, heart failure, and end-stage renal disease (ESRD). Furthermore, sex-related differences in the
prognostic impact of exercise test variables and cardiovascular comorbidities should be accounted for.9,10 We therefore
aimed to develop comprehensive sex-specific risk scores to estimate all-cause mortality in a more inclusive and contemporary population. We then determined whether these sexspecific risk scores better estimated mortality when compared
with the DTS and Lauer nomogram. Finally, we validated these
sex-specific risk scores by assessing discrimination and calibration in an external cohort.

Methods
Cleveland Clinic Cohort
From a cohort of 60 895 consecutive patients undergoing
symptom-limited treadmill testing at the Cleveland Clinic
Foundation (CCF) from January 1, 2000, to December 31, 2010,
1018 were excluded owing to atrial fibrillation, a resting electrocardiogram that precluded interpretation of the ST segment, digoxin use, being younger than 18 years, or having no
Social Security number available. The final CCF cohort included 59 877 patients.
At the time of stress testing, patient demographic characteristics, comorbidities, and medications were prospectively
entered into a stress database. Known CAD was defined as a
previous myocardial infarction, previous percutaneous coronary intervention, or a history of coronary artery bypass grafting. Heart failure was defined by self-reported history and review of the medical record. Hypertension was defined as selfreported history or use of antihypertensives. Hyperlipidemia
was defined as an abnormal fasting lipid panel according to
Adult Treatment Panel III guidelines, self-reported history, or
use of medications to lower lipid levels. Diabetes was defined
as a fasting blood glucose level of at least 126 mg/dL (to convert to millimoles per liter, multiply by 0.0555), self-reported
16

Key Points
Question Do sex-specific risk scores better estimate all-cause
mortality for patients undergoing exercise treadmill testing?
Findings In a retrospective cohort study of nearly 110 000
patients, sex-specific risk scores better estimated mortality.
Exercise capacity had the greatest effect on prognosis in both
sexes, and all risk factors had a differential effect on prognosis in
women compared with men.
Meaning Risk stratification is improved with sex-specific risk
scores, and in particular, patients at the highest risk are more
readily identified.

history, or use of medication to lower glucose levels. Patients
who were actively smoking cigarettes or who had smoked
within the past year were considered current smokers, and patients who had smoked less recently were considered to have
a history of smoking. We defined ESRD as receiving dialysis.
Patients underwent symptom-limited treadmill testing
using a protocol based on a pretest estimation of exercise capacity and designed to have the patient reach maximal exertion within 8 to 12 minutes, as suggested by exercise testing
guidelines.1 Standard exercise protocols were used, and most
patients performed a Bruce protocol (61%). Other protocols included Cornell, Naughton, modified Naughton, and modified Bruce.1 Heart rate targets were not used as an end point
or to judge the adequacy of the test. The ST segment was measured 80 milliseconds after the J point, and the magnitude of
ST depression was recorded as the greatest horizontal or downsloping ST-segment depression in any lead except aVR during the test or in recovery.
Blood pressure was measured during every stage of the
test. Heart rate was recorded from an electrocardiogram printed
every minute during the test. Peak estimated metabolic equivalents of task (METs) were calculated from treadmill speed and
grade at peak exercise. Chest discomfort during the test was
recorded as none, nonlimiting chest pain, or test-limiting chest
pain. Rate-pressure product (RPP) was calculated as the product of heart rate and systolic blood pressure. A ΔRPP was calculated as RPP at peak exercise minus RPP at rest. Heart rate
recovery (HRR) was calculated as peak exercise heart rate minus heart rate at 1 minute after exercise.
Patients were given a standard walking recovery for tests
involving electrocardiography only, technetium imaging, or
metabolic stress testing. For patients undergoing stress echocardiography, a supine recovery immediately after exercise
was used. Therefore, HRR at 1 minute was classified as abnormal if 12 or fewer beats/min for patients undergoing upright
recovery and abnormal if 18 or fewer beats/min in patients undergoing stress echocardiography.5,11,12 Chronotropic reserve
index was calculated as (Peak heart rate – resting heart rate)/
[(220 – age) – resting heart rate] and was considered abnormal if no greater than 0.8 for patients not taking a β-blocker
and abnormal if at least 0.62 for patients taking a β-blocker.
In patients who did not undergo a Bruce protocol, the estimated METs achieved by each patient were converted to minutes per the Bruce protocol before calculation of the DTS.
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The DTS was calculated as Exercise time – (5 × maximum
ST-segment depression) – (4 × treadmill chest pain index).
Treadmill chest pain was scored from 0 to 2, with 0 representing no chest pain; 1, nonlimiting chest pain; and 2, chest pain
for which the exercise test was terminated.2

Validation Cohort
The Henry Ford Exercise Testing (FIT) cohort is from a registry of 69 885 consecutive patients who had physicianreferred exercise treadmill tests at the Henry Ford Health
System from January 1, 1991, through December 31, 2009.
Methodologic details have been reported previously.13 In
brief, patients older than 18 years who underwent exercise
treadmill tests were included. All testing used the standard
Bruce protocol. Exercise test, medical history, and medication data were collected at the time of testing, and supporting clinical data were derived from the electronic medical
record and administrative databases. For external validation
purposes, the 3880 patients without recorded weight and
the 16 727 without glomerular filtration rate data were
excluded. A final sample size of 49 278 patients was included
for external validation.
All data in both cohorts were deidentified. The institutional review boards at CCF, Henry Ford Health System, and
Johns Hopkins Hospital approved this study with an exemption for individual patient consent.

Outcome
The primary outcome was all-cause mortality and was determined from the Social Security Death Index Master File. Previous work14 demonstrated that more than 95% of the time the
Social Security Death Index correctly identifies patients who
have died. The final censoring date was October 27, 2011, in
the CCF cohort, and April 1, 2013, in the FIT cohort.

Statistical Analysis
Data were analyzed from January 1, 2000, to October 27, 2011,
in the CCF cohort and from January 1, 1991, to April 1, 2013, in
the FIT cohort. For men and women, the CCF sample was divided randomly, with 50% of patients in the derivation cohort and 50% in the validation cohort. All data analysis to develop risk scores was performed in the derivation cohorts. Data
are summarized as median and interquartile range (IQR) for
continuous data and number (percentage) of nonmissing data
for categorical variables. Comparisons across age categories and
survival status used 2-tailed unpaired t tests for continuous
variables and χ2 tests for categorical variables. Cox proportional hazards regression models were used to create separate multivariable models for men and women to determine
independent risk factors for all-cause mortality.
All variables that were significantly associated with allcause mortality on univariable analysis (P < .05) were considered for multivariable adjustment. Bootstrapping methods
were used to identify variables for inclusion in the final models. Two hundred bootstrapped models were generated for men
and women; variables that were entered into the models at least
50% of the time were then entered into a backward stepwise
selection modeling process to create separate Cox models for
jamacardiology.com
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men and women. These Cox models were validated for calibration accuracy to estimate overall survival (eMethods in the
Supplement).
The Cox models from the derivation cohort were then used
to develop sex-specific risk scores for estimating mortality. To
assign value to each variable in creating a risk score, categories were created for the continuous variables in the model.
Creation of these categories was based on the distribution of
each variable. Linearity was tested with restricted cubic splines.
Continuous variables were divided into quartiles with the exception of age for women and weight for men. The β coefficients across quartiles were similar for these variables; thus,
age for women was divided into older than 65 years or 65 years
or younger, and weight for men was divided into more than
80 kg or 80 kg or less. The β coefficients of each covariate in
these categories were then used to assign points for every risk
factor (eMethods in the Supplement). The points were then
added together to obtain a total score. Overall, 7% of data were
missing. To reduce bias in estimates and uncertainty related
to the imputation model, multiple imputation of missing variables was performed with a regression-based method. In the
CCF validation cohorts, discrimination was assessed with receiver operating characteristic curves and Harrell C statistics,
category-free net reclassification improvement, and integrated discrimination improvement.15
The FIT cohort served as an external validation cohort. The
risk scores were modified because certain data were not available in both cohorts. Heart rate recovery was not available in
the FIT database and was excluded from the models using this
cohort. A history of smoking was not available in the FIT cohort and was replaced with current smoking. Finally, ESRD was
not categorized in the FIT cohort and was replaced by glomerular filtration rate of less than 15 mL/min/1.73 m2. Discrimination with these modifications to the risk scores was assessed
with receiver operating characteristic curves and Harrell C statistics. Calibration was assessed by dividing the risk scores into
deciles for men and women and plotting observed vs predicted mortality.
All analyses were performed using SAS (version 9.2; SAS Institute Inc), R (R CoreTeam 2015 [http://www.R-project.org/]),
and STATA (version 14.0; StataCorp) statistical software. Twotailed P < .05 was considered statistically significant.

Results
Patient Characteristics
Owing to known differences in the prevalence and impact of
comorbidities and exercise variables between men and
women,10 the 59 877 patients in the CCF cohort were divided
by sex (59.4% men; 40.5% women) for all analyses. Overall,
the median age was 54 (IQR, 45-63) years, and 66.4% of the
population was white. Cardiovascular comorbidities were more
common in men, especially a history of CAD (24.2% vs 9.2%).
Exercise capacity was generally preserved, and men had higher
exercise capacity (10 [IQR, 8.3-11.5] vs 8 [IQR, 6.6-10] METs)
and DTSs (8.5 [IQR, 5.5-10.2] vs 6.5 [IQR, 4-8.2]) compared with
women (Table 1). In the FIT cohort (52.5% men; 47.4%
(Reprinted) JAMA Cardiology January 2017 Volume 2, Number 1
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Table 1. Baseline Clinical, Medication, and Exercise Data for the CCF Cohort
CCF Cohort, No. (%)
Overall
(n = 59 877)

Data

Women
(n = 24 292)

Men
(n = 35 585)

P Value

Clinical
Age, median (IQR), y

54 (45-63)

White race

39 753 (66.4)

53 (45-62)

54 (45-63)

15 201 (62.6)

24 552 (69)

BMI, median (IQR)

28 (24.9-31.7)

27.5 (23.7-32.2)

Body weight, median (IQR), kg

84 (72-97)

73 (63-86)

Diabetes

.007
<.001

28.2 (25.6-31.4) <.001
89 (80-101)

<.001

6924 (11.6)

2635 (10.8)

4289 (21.1)

<.001

27 142 (45.3)

10 610 (43.7)

16 532 (46.4)

<.001

Hyperlipidemia

31 594 (52.8)

11 610 (47.8)

19 984 (56.2)

<.001

History of smoking

26 894 (44.9)

9735 (40.1)

17 159 (48.2)

<.001

Hypertension

Current smoker

7361 (12.3)

2988 (12.3)

4373 (12.3)

Family history of CAD

19 927 (33.3)

8655 (35.6)

11 272 (31.7)

<.001

.82

CAD

10 855 (18.1)

2225 (9.2)

8630 (24.2)

<.001

Previous
MI

4766 (8)

957 (3.9)

3809 (10.7)

<.001

PCI

4370 (7.3)

853 (3.5)

3517 (9.9)

<.001

CABG

3181 (5.3)

466 (1.9)

2715 (7.6)

<.001

900 (1.5)

349 (1.4)

551 (1.5)

.14

1350 (2.3)

532 (2.2)

818 (2.3)

.17

918 (1.5)

333 (1.4)

585 (1.6)

.002

COPD
Stroke or TIA
CHF
ESRD

264 (0.4)

84 (0.3)

180 (0.5)

.002

PVD

684 (1.1)

221 (0.9)

463 (1.3)

<.001

Medications
Aspirin
Clopidogrel
β-Blocker

22 692 (37.9)

7228 (29.8)

3339 (5.6)

856 (3.5)

14 848 (24.8)

5683 (23.4)

ACEI or ARB

14 964 (25)

5110 (21)

Statin

18 990 (31.7)

5950 (24.5)

15 464 (43.4)

<.001

2483 (7)

<.001

9165 (25.8)

<.001

9854 (27.7)

<.001

13 040 (36.6)

<.001

Exercise data
Rest
Heart rate, median (IQR),
beats/min

69 (62-78)

73 (65-82)

67 (60-76)

<.001

Systolic BP, median (IQR),
mm Hg

128 (118-140)

126 (112-140)

130 (118-142)

<.001

RPPa

8.9 (7.6-10.5)

No ST depression

47 444 (79.2)

Chest pain

9.2 (7.8-10.8)

27 816 (78.2)
1071 (3)

<.001
<.001

1623 (2.7)

552 (2.3)

Termination owing to chest pain

927 (1.5)

362 (1.5)

565 (1.6)

Maximum heart rate, median
(IQR), beats/min

157 (144-171)

157 (144-170)

159 (144-171)

<.001

a

<.001
.36

Maximum RPP, median (IQR)

28.1 (24.2-31.8)

26.8 (23.3-30.3)

29 (25-32.8)

<.001

Maximum ΔRPP, median (IQR)b

18.8 (14.9-22.6)

17.3 (13.9-20.6)

20.1 (16-23.7)

<.001

10 (8.3-11.5)

<.001

Peak METs, median (IQR)
Abnormal HRRc
Abnormal CRId
DTS, median (IQR)

9.3 (7.2-11)

8 (6.6-10)

9704 (16.2)

3948 (16.3)

5756 (16.2)

.81

11 156 (18.6)

4993 (20.6)

6163 (17.3)

<.001

7.5 (4.5-9.5)

6.5 (4-8.2)

women), the median (IQR) age was also 54 (46-64) years, 63.9%
were white, and cardiovascular comorbidities were common
(eTable 1 in the Supplement).

Univariable Associations With Increased Mortality
In the CCF cohort, during a median follow-up of 7 (IQR, 4.19.6) years, 2521 deaths occurred (4.2% mortality), with 742
18

8.7 (7.4-10.2)

19 628 (81)

8.5 (5.5-10.2)

<.001

a

Calculated as (heart rate × systolic
BP)/1000.

b

Calculated as maximal RPP minus
resting RPP.

c

Calculated as peak exercise heart
rate minus heart rate at 1 minute
after exercise.

d

Calculated as (peak heart
rate − resting heart
rate)/[(220 − age) − resting heart
rate].

deaths in women (3.1% mortality) and 1779 deaths in men (5%
mortality). In both sexes, death was associated with increased age, lower body weight, diabetes, hypertension, hyperlipidemia, current or former smoking, CAD, myocardial infarction, percutaneous coronary intervention, coronary artery
bypass grafting, chronic obstructive pulmonary disease, stroke
or transient ischemic attack, heart failure, ESRD, and periph-
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Abbreviations: ACEI, angiotension
converting enzyme inhibitor;
ARB, angiotension receptor blocker;
BMI, body mass index (calculated as
weight in kilograms divided by height
in meters squared); BP, blood
pressure; CABG, coronary artery
bypass graft; CAD, coronary artery
disease; CCF, Cleveland Clinic
Foundation; CHF, congestive heart
failure; COPD, chronic obstructive
pulmonary disease; CRI, chronotropic
response index; DTS, Duke Treadmill
Score; ESRD, end-stage renal disease;
HRR, heart rate recovery;
IQR, interquartile range;
METs, estimated metabolic
equivalents; MI, myocardial
infarction; PCI, percutaneous
coronary intervention;
PVD, peripheral vascular disease;
RPP, rate-pressure product;
TIA, transient ischemic attack.
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eral arterial disease. In men, death was also associated with a
lower body mass index and a family history of coronary disease. With regard to exercise variables, death was associated
with ST-segment depression, lower maximal heart rate, lower
maximal RPP and ΔRPP, lower peak METs, an abnormal HRR,
and an abnormal chronotropic reserve index. A lower DTS was
also associated with increased mortality, but no association was
found between nonlimiting or limiting chest pain and mortality (eTable 2 in the Supplement).

Original Investigation Research

Table 2. Sex-Specific Exercise and Clinical Risk Scores
for Estimating Mortality
Variable

Points

Women
Peak treadmill METs
<5

10

5-7

8

7-10

4

ESRD

Developing the Sex-Specific Risk Scores
In multivariable Cox models, lower peak estimated METs, abnormal HRR, increasing age, lower body weight, current or former smoking, and ESRD were all associated with mortality in
men and women (eTable 3 in the Supplement). In addition, a
history of diabetes was associated with mortality in women,
whereas a history of heart failure and hypertension were associated with mortality in men. These Cox models showed good
calibration at predicting mortality at 10 years (eFigure 1 in the
Supplement). The β coefficients from these Cox proportional
hazards regression models were then used to assign points for
each covariate (Table 2). The final risk scores for women and
men showed high discrimination in estimating mortality in the
derivation cohorts (C statistic for women, 0.82; C statistic for
men, 0.81).

Kaplan-Meier Survival Analysis
Although the DTS was associated with mortality when assessed as a continuous variable, differentiation of risk was limited when assessed according to the typical DTS categories. In
particular, few patients had high-risk DTSs that resulted in wide
and overlapping 95% CIs. Similar results were obtained in men
and women (Figure 1A and C). Of note, 78 women (0.3%) and
221 men (0.6%) had high-risk DTSs. Conversely, survival curves
using the sex-specific risk scores effectively identified patients at highest risk for all-cause mortality (Figure 1B and D),
as is also evident in the estimate of 10-year mortality risk according to the sex-specific risk scores (eTables 4 and 5 in the
Supplement).

Validating the Risk Scores
For the sex-specific risk scores, C statistics were similar in the
CCF validation cohorts (0.79 for women and 0.81 for men).
These sex-specific risk scores also performed better at estimating mortality when compared with the other models in
women (C statistic for DTS, 0.70; C statistic for Lauer nomogram, 0.74) (eFigure 2A in the Supplement) and in men (C statistic for DTS, 0.72; C statistic for Lauer nomogram, 0.75) (eFigure 2B in the Supplement). Category-free net reclassification
improvement and integrated discrimination improvement were
also significantly improved with the sex-specific risk scores
when compared with the DTS and the Lauer nomogram
(Table 3). This improved discrimination primarily corresponded to the correct reclassification of patients who died.
Finally, sex-specific risk scores were calculated for patients in the FIT cohort to assess external validation. At a median follow-up of 10.2 years, there were 6643 deaths in a population of 49 278 (13.5%). The C statistics for the sex-specific risk
jamacardiology.com

5

Weight, kg
<50

4

50-70

3

70-90

2

Age >65 y

1

Abnormal HRR

2

Former/current smoking

2

Diabetes

1

Men
Peak treadmill METs
<8

10

8-10

6

10-12

4

ESRD

7

Weight <80 kg

1

Age, y
55-65

1

65-75

4

>75

7

Abnormal HRR

3

Former/current smoking

1

History
Hypertension

2

Heart failure

5

Abbreviations: ESRD, end-stage renal disease; HRR, heart rate recovery;
METs, metabolic equivalents.

scores were similar in women (0.78) and men (0.79). Regarding calibration, good tracking of observed vs predicted mortality was found (Figure 2).

Discussion
The present study is, to our knowledge, the largest to date to
develop sex-specific prognostic risk scores using treadmill testing data. We have demonstrated excellent discrimination and
calibration for estimating mortality in the CCF derivation and
validation cohorts. Moreover, in the CCF validation cohort,
C statistics, net reclassification improvement, and integrated
discrimination improvement with these new sex-specific risk
scores were improved compared with the DTS and Lauer nomogram. Finally, discrimination and calibration were also reasonable when the sex-specific risk scores were tested externally in the FIT cohort.
A few important observations from our study should be
highlighted. First, in patients undergoing treadmill testing, our
(Reprinted) JAMA Cardiology January 2017 Volume 2, Number 1
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Figure 1. Kaplan-Meier Survival Analysis for Women and Men in the Cleveland Clinic Foundation (CCF) Cohort
A Duke Treadmill Scores among women

B

Sex-specific risk scores among women
100
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D Sex-specific risk scores among men

Duke Treadmill Scores among men
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No. at risk
No. at risk
221
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207
199
192
179
158
138
127
High
Tertile 1
Intermediate 6182 6077 5709 5324 4951 4534 4055 3502 2965 Tertile 2
Low
Tertile 3
29 182 28 696 26 469 24 222 21 971 19 601 17 146 14 617 11 967

11 155 11 035 10 268 9443
12 653 12 482 11 597 10 715
11 777 11 475 10 520 9587

8652
9776
8686

The CCF cohort included 24 292 women and 35 585 men. Data points indicate median; error bars, 95% CI. Duke Treadmill Scores are stratified as low, intermediate,
and high risk. The sex-specific risk scores are stratified into tertiles.

Table 3. Discrimination Analysis for the CCF Cohort Comparing
the NRSs With the DTS and Lauer Nomogram in Women and Men
% (95% CI)
Discrimination Analysis
IDI: NRSs vs DTS

Women
20 (18.7-21.3)

Men
19 (18.2-19.8)

NRSs vs DTS

75.8 (68.1-83.6)

81.6 (76.3-86.8)

Events correctly reclassified

66.5 (58.9-74)

63.2 (58.1-68.2)

Category-free NRI

Nonevents correctly reclassified
IDI: NRSs vs Lauer nomogram

9.4 (7.5-11.2)

18.4 (16.9-19.9)

23 (21.7-24.4)

24 (23.2-24.8)

NRSs vs Lauer nomogram

80.1 (72.6-87.6)

87.3 (82.5-92)

Events correctly reclassified

69.2 (61.9-76.5)

72 (67.5-76.5)

Previous Studies

Nonevents correctly reclassified

10.9 (9.1-12.7)

15.3 (13.8-16.8)

The DTS remains the most common method to assess prognosis in patients with exercise testing, although this score was
developed in higher-risk patients—predominantly middleaged men—who all had chest pain and invasive coronary
angiography.2 In a lower-risk and more diverse patient population, our study demonstrates that the prognostic value of the
DTS is related solely to the importance of exercise capacity.
Chest pain and ST depression with exertion were not associ-

Category-free NRI

Abbreviations: CCF, Cleveland Clinic Foundation; DTS, Duke Treadmill Score;
IDI, integrated discrimination improvement; NRI, net reclassification
improvement; NRSs, sex-specific new risk scores.

data support separate risk scores according to sex. Certain variables are present or absent in the models for men vs women,
and the hazard ratios for risk factors common to both models
20

differ according to sex. Therefore, rather than simply adjusting for sex, we argue that a sex-specific approach should be considered when assessing the prognosis for patients who undergo exercise testing. In addition, although many variables
are associated with mortality and refine risk stratification, decreased exercise capacity is the most important risk factor for
men and women. Finally, as shown in our category-free net
reclassification improvement, the major advantage of our risk
scores is the identification of patients who are likely to have a
fatal event. As cardiovascular mortality continues to decline,3
identification of patients with the highest residual risk is increasingly important.
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Figure 2. Estimated vs Observed Mortality for Women and Men in the Henry Ford Hospital Exercise Testing
(FIT) Cohort
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ated with mortality in multivariable models. The Lauer nomogram improved on the DTS by incorporating other exercise variables and comorbidities.8 However, notable patient
populations were excluded. Our objective was to create more
comprehensive risk scores with a more inclusive patient population. This approach facilitates a broader clinical use for our
sex-specific risk scores.

In the FIT cohort (23 386 women,
25 892 men), the sex-specific risk
score was slightly altered to exclude
abnormal heart rate recovery and to
define end-stage renal disease as a
glomerular filtration rate of less than
15 mL/min/1.73 m2.

ment, especially because HRR has emerged as a risk factor
in several studies.7,11,12,18 In fact, in a well-developed model,
little change may occur in the C statistic when an additional
variable is added, even if that variable improves risk
stratification.19

Conclusions

Limitations
Our study has several notable limitations. First, we assessed
all-cause instead of cardiac death, although all-cause mortality may be preferred because it is an unbiased end point.
Second, imaging data were not included in our analysis and
have been shown to have prognostic importance.16,17 However, the focus of this study was to develop risk scores
based on clinical and exercise variables alone. Third, all
patients in the study underwent evaluation at large referral
centers, and generalizability to smaller hospitals may be
limited. Finally, because of differences in data collection,
the risk scores tested in the FIT cohort were similar, but not
identical, to the scores used in the CCF cohort. Discrimination was good in both cohorts, but this observation should
not lead to the exclusion of certain variables in risk assess-
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Invited Commentary

Can We Improve Mortality Estimation in Women
After Treadmill Testing by Using Sex-Specific Scores?
Ashok Krishnaswami, MD, MAS; Jeff W. Christle, MA; Victor Froelicher, MD

The use of predictive analytics in modern cardiology has
had a significant impact in decreasing the subjectivity of
forecasting cardiovascular events. The abundance of currently available clinical prediction models (CPMs) has
Related article page 15
been demonstrated by a
recent systematic review. 1
This review unearthed 796 scientific articles on the topic of
CPMs and cardiovascular disease published from 1990 to
2012, with 90% being novel and the remainder recalibration
or other adaptations of prior CPMs. Although utilization of
CPMs is currently low, it promises to decrease use of the routine subjective eyeball test.2
To establish an anatomical diagnosis of coronary artery
disease and to estimate the probability of future cardiac
events is a difficult task. This concept is not dissimilar to the
Heisenberg “uncertainty principle” in which a particle’s
position and momentum cannot be known with complete
precision. 3 Therefore, working in this arena requires an
acceptance of some uncertainty. The exercise treadmill test
has been recommended as a routine first-line test for individuals capable of exercising with no contraindications and
without an abnormal resting electrocardiographic finding.4
However, concern about its low sensitivity and specificity
(leading to false-positive findings), owing to an undue focus
on the ST segment often results in the use of additional
imaging modalities (myocardial perfusion or echocardiography). Advanced CPMs have come to the rescue and have
been shown to be superior to subjective prognostication.5
22

They have improved the accuracy of diagnosis of coronary
artery disease and the prognosis of future cardiovascular
events, reduced costs, and aided the decision-making
process.6,7
In this issue of JAMA Cardiology, Cremer et al8 have tied
together 3 important areas in cardiovascular medicine: the
use of CPMs, sex-specific research,9 and treadmill testing.
The investigators used the Cleveland Clinic Foundation
(CCF) cohort for derivation and internal validation and the
Henry Ford Exercise Testing (FIT) cohort for external validation. The study examined the hypothesis that sex-specific
CPMs are superior to general models that have been risk
adjusted for sex, such as the Lauer score.10 The models were
tested using standard discrimination and calibration statistics. Patients in the CCF cohort underwent symptom-limited
treadmill testing using multiple treadmill protocols. Comorbidities were obtained at the time of the baseline treadmill
test. Subsequent prognostic variables, such as the Duke
Treadmill Score, chronotropic reserve index, and ratepressure product, were then calculated using standard
treadmill variables that were also obtained at the time of
baseline testing. The primary outcome of all-cause mortality
was determined by the Social Security Death Index Master
File. Covariate β coefficients were obtained using time-toevent analysis (Cox proportional hazards regression model)
with a backward-stepwise covariate selection that was subsequently used to develop a linear score.
The study findings demonstrated that the women referred for exercise testing were younger, were less often white,
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